Theresa Mullis v. HHS - Influenza, transverse myelitis (2019)
Case summary [AI summaries can sometimes make mistakes]
Theresa Mullis filed a petition on March 20, 2017, seeking compensation under the National Vaccine Injury Compensation Program. She alleged that she suffered from transverse myelitis as a result of an influenza vaccine she received on September 22, 2015.
The respondent initially recommended that Ms. Mullis be denied compensation.
However, the parties engaged in settlement negotiations. Although the respondent maintained the position that the influenza vaccine did not cause Ms.
Mullis's injury, the parties filed a stipulation on March 8, 2019. Special Master Brian H.
Corcoran reviewed the record and found the stipulation to be reasonable, adopting it as the decision. The stipulation awarded Ms.
Mullis a lump sum of $150,000.00, payable by check to Petitioner, as compensation for all damages under Section 15(a) of the Act. The public decision does not describe the specific onset of symptoms, medical tests, treatments, or expert witnesses.
Ronald C. Homer represented the Petitioner, and Justine E.
Walters represented the Respondent. The decision was issued on May 1, 2019.
Theory of causation
Petitioner Theresa Mullis alleged that she suffered from transverse myelitis as a result of an influenza vaccine received on September 22, 2015. The respondent maintained that the vaccine did not cause the injury. The parties filed a stipulation, and Special Master Brian H. Corcoran adopted it as the decision, awarding Petitioner $150,000.00. The public decision does not detail the specific theory of causation, medical experts, or the mechanism of injury. The case was settled via stipulation, with Petitioner represented by Ronald C. Homer and Respondent by Justine E. Walters. The decision date was May 1, 2019.
Source PDFs
USCOURTS-cofc-1_17-vv-00390